E3999
|
ECOG
|
A Randomized; Placebo-controlled; Double Blind; Trial of the Administration of the MDR Modulator; Zosuquidar Trihydrochloride (LY335979); During Conventional Induction and Post-Remission Therapy in Patients Greater than 60 Years of Age with Newly Diagnosed Acute Myeloid Leukemia; Refractory Anemia with Excess Blasts in Transformation or High-Risk Refractory Anemia with Excess Blasts
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
E3A06
|
ECOG
|
Randomized Phase III Trial of Lenalidomide versus Observation Alone In Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E3F05
|
ECOG
|
Phase III Study of Radiation Therapy with or without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E4201
|
ECOG
|
A Randomized Phase III Study of Gemcitabine in Combination with Radiation Therapy Versus Gemcitabine Alone in Patients with Localized; Unresectable Pancreatic Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
E4402
|
ECOG
|
Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens for Patients with Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E4412
|
ECOG-ACRIN
|
A Phase I Study with an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E4512
|
ECOG
|
A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E4599
|
ECOG
|
Randomized Phase II/III Trial of Paclitaxel plus Carboplatin With or Without Bevacizumab (NSC #704865) in Patients with Advanced Nonsquamous NSCLC
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
E4A03
|
ECOG
|
A Randomized Phase III Study of CC-5013 Plus Dexamethasone Versus CC-5013 Plus Low Dose Dexamethasone in Multiple Myeloma with Thalidomide Plus Dexamethasone Salvage Therapy for Non-Responders
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E4A08
|
ECOG
|
A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) versus Bortezomib; Melphalan; and Dexamethasone (BMDex) for Untreated Patients with Systemic Light-chain (AL) Amyloidosis Ineligible for Autologous Stem-cell Transplantation
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|